Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leukemia
Condition(s):Acute Myeloid LeukemiaLast Updated:February 26, 2021Unknown status
Hide Studies Not Open or Pending
Condition(s):Acute Myeloid LeukemiaLast Updated:February 26, 2021Unknown status
Condition(s):Acute Myelogenous Leukemia; Myelodysplastic SyndromesLast Updated:June 4, 2018Unknown status
Condition(s):Acute Myeloid Leukemia; AML, Childhood; Relapsed Pediatric AML; Refractory Pediatric AMLLast Updated:December 8, 2023Withdrawn
Condition(s):Therapy Related Myelodysplastic Syndrome and Therapy Related Acute Myeloid LeukemiaLast Updated:May 19, 2020Completed
Condition(s):AMLLast Updated:April 21, 2022Recruiting
Condition(s):Acute Myeloid LeukemiaLast Updated:March 9, 2022Completed
Condition(s):AMLLast Updated:July 7, 2015Unknown status
Condition(s):AML; AdultLast Updated:October 12, 2022Terminated
Condition(s):AML, AdultLast Updated:January 29, 2024Recruiting
Condition(s):AML; Pediatric AMLLast Updated:January 18, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.